The India Task Force is driving nationally relevant progress in pulmonary arterial hypertension (PAH) care, research, and education across India. Working closely with PVRI’s global network, the group focuses on improving early diagnosis, strengthening clinical collaboration, and developing guidance that reflects the realities of the Indian healthcare system.
What we’ve been working on
The Task Force has made significant strides in building the foundations for consistent, high-quality PAH care nationwide:
India’s first national PAH guidelines have been finalised for submission — a landmark, India-wide guidance developed through PVRI collaboration
A multicentre yoga trial in PAH has been initiated, exploring culturally relevant supportive therapies
Digital stethoscope screening initiatives are being implemented to support earlier detection of PAH
What’s next
Momentum is building, with a strong focus on turning guidance into action:
Publication and nationwide dissemination of the Indian PAH guidelines
Expanded participation in multicentre registries and pragmatic studies to strengthen real-world evidence from India
National Pulmonary Hypertension Symposium 2026 📅 28 February 2026 & 01 March 2026 | 📍 Bengaluru
The India Task Force is supporting this two-day national meeting focused on advancing clinical practice, collaboration, and research in PH across India. The programme spans the full PH spectrum, with practical sessions on risk stratification, imaging, advanced therapies, transplantation, and multidisciplinary care.
This meeting will bring clinicians together to share expertise, strengthen networks, and continue building nationally relevant PH guidance and research.
PVRI’s latest report highlights how global IDDI Workstreams and Task Forces are accelerating progress in pulmonary hypertension research, care, and innovation. Discover key achievements from across regions and specialties.
Interested in accessing global data on PH patient experience? Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
